Non variceal upper gi bleeding

1. _________________________________
* Corresponding author:
N.Junior Sundresh,
Associate Professor of Surgery,
Raja Muthiah Medical College & Hospital,
Chidambaram. -
Tamilnadu.
E.Mail: juniorsundresh@yahoo.com
Available Online at: www.ijrpp.com
FIND OUT THE PREVALANCE OF VARIOUS
DISEASES PRODUCING
*1
N.Junior sundresh, 2
S.Narendran,
1
Associate Professor of Surgery
University, Chidambaram.
2
Emeritus Professor of Surgery,
University, Chidambaram.
3
Professor of Surgery Raja Muthiah Medical College &
Chidambaram.
_____ _______________________________
ABSTRACT
Non variceal upper G.I bleeding is the bleeding from a source proximal to the ligament of teres. Advances in
medical technology particulars the increased availability and application or diagnostic and the operatic endoscopy
have been instrumented in evaluated and successful treatment of patients with major bleeding. This study aims to
find out various non-variceal diseases producing upper G.I. bleeds and the various modalities of treatment.
Keywords: Non variceal upper G.I bleeding
_____________________________________________________
INTRODUCTION
Upper GI bleeding is defined as bleeding from a
source proximal to the ligament of teres. It is
common and potentially deadly condition
accounting for approximately 85% of hospital
admissions for G.I. bleeding upper GI bleeding
presents as hematemesis and it melena. Numerous
advances in medical technology, particularly the
improved availability and applications of diagnostic
and therapeutic endoscopy have been instrumental
in the evaluation and successful treatment of
patients with major bleeding.
_________________________________
Raja Muthiah Medical College & Hospital,
Available Online at: www.ijrpp.com Print ISSN : 2278 - 2648
Online ISSN: 2278 - 2656
(Research article)
FIND OUT THE PREVALANCE OF VARIOUS NON-VARICEAL
DISEASES PRODUCING UPPER GI BLEEDING
S.Narendran, 3
M.Ramanathan
Surgery, Raja Muthiah Medical College & Hospital, Annamalai
Professor of Surgery, Raja Muthiah Medical College & Hospital, Annamalai
Raja Muthiah Medical College & Hospital, Annamalai University
______________________________________________________________
Non variceal upper G.I bleeding is the bleeding from a source proximal to the ligament of teres. Advances in
technology particulars the increased availability and application or diagnostic and the operatic endoscopy
have been instrumented in evaluated and successful treatment of patients with major bleeding. This study aims to
es producing upper G.I. bleeds and the various modalities of treatment.
bleeding, hematemesis, Melena
__________________________________________________________________________________________
Upper GI bleeding is defined as bleeding from a
source proximal to the ligament of teres. It is
common and potentially deadly condition
approximately 85% of hospital
admissions for G.I. bleeding upper GI bleeding
elena. Numerous
advances in medical technology, particularly the
improved availability and applications of diagnostic
e been instrumental
in the evaluation and successful treatment of
The main aim of the study is,
 To find out the prevalence of various non
variceal diseases producing upper GI bleed.
 To study the various modalities of
treatment and also to study those cases
which will require emergency surgery with
special attention to endoscopy.
 To plan the mode of management with
respect to non-variceal upper GI bleeding in
the future.
International Journal of
Research in Pharmacology and
Pharmacotherapeutics
46
(Research article)
VARICEAL
Muthiah Medical College & Hospital, Annamalai
Raja Muthiah Medical College & Hospital, Annamalai
Hospital, Annamalai University,
_______________________________
Non variceal upper G.I bleeding is the bleeding from a source proximal to the ligament of teres. Advances in
technology particulars the increased availability and application or diagnostic and the operatic endoscopy
have been instrumented in evaluated and successful treatment of patients with major bleeding. This study aims to
es producing upper G.I. bleeds and the various modalities of treatment.
________________________
To find out the prevalence of various non-
variceal diseases producing upper GI bleed.
To study the various modalities of
treatment and also to study those cases
which will require emergency surgery with
special attention to endoscopy.
To plan the mode of management with
variceal upper GI bleeding in
Journal of
Research in Pharmacology and
Pharmacotherapeutics

2. 47
N.Sundresh et et al / Int. Jour. of Res. in Pharmacology and Pharmacotherapeutics Vol-1[1] 2012 [46-51]
www.ijrpp.com
.Materials and Methods
Forty seven cases of upper bleeding were admitted
during the period of 3 years of study in RMMCH,
Chidambaram. As soon as the patient is admitted a
detailed history is taken from the close relatives of
the patient to understand the nature and amount of
blood loss during the history taking itself. All
relevant investigations were done.
Results
Out of the 47 patients, majority of cases (around 16)
were from the age group 41-50 years. Minimum age
incidence was found in the age group 11-20 years
out of the 47 patients 36 were male and 11 were
female, the male: female ratio being 3:1 the most
common mode of presentation was haematemesis,
and least was melena. Erosive gastritis was the most
common etiological factor. Most of the cases were
managed conservatively.
Discussion
The total of 47 patients studied, majority was in the
age group of 41-50 years with male prominence.
Haematemesis is the predominant presenting
symptom with the introduction of upper GI
endoscopy. Source of bleeding can be detected in
more than 90% of cases. The introduction of proton
pump inhibitors and availability of easily endoscopic
management has brought down the complication
and need for survey in peptic ulcer disease. Through
the necessity of emergency surgery has considerably
reduced it is still preferred to be the important life-
saving produce for those patients who do not
respond to conjunctive line of management.
Table: 1
Age Incidence
Age in Years No. of cases Percentage
11 – 20 1 21.2 %
21 – 30 6 12.76 %
31 – 40 10 21.27 %
41 – 50 16 34.04 %
51 – 60 8 17.02 %
61 – 70 4 8.51 %
71 – 80 2 4.25 %

3. 48
N.Sundresh et et al / Int. Jour. of Res. in Pharmacology and Pharmacotherapeutics Vol-1[1] 2012 [46-51]
www.ijrpp.com
Table: 2
Sex Incidence
Sex No. of cases Percentage
Male 36 76.59 %
Female 11 23.4 %
Table: 3
Presenting Symptom
Symptom No. of Cases Percentage
Haematemesis 32 68.08 %
Melena 3 6.38 %
Haematemesis and melena 12 25.53 %
Table: 4
Presenting Symptom
Lesions Identified No. of Cases Percentage
Erosive gastritis 29 61.70 %
Duodenal ulcer 10 21.27 %
Gastric ulcer 2 4.25%
Mallory – Weiss tear 2 4.25%
Carcinoma stomach 2 4.25%
Dieulafoy’s lesion 1 2.12%
Necrotizing pancreatitis 1 2.12%

4. 49
N.Sundresh et et al / Int. Jour. of Res. in Pharmacology and Pharmacotherapeutics Vol-1[1] 2012 [46-51]
www.ijrpp.com
Table: 5
Diagnosis and Outcome
Diagnosis No. of Cases Conservative Surgery Mortality
Erosive gastritis 29 100 % - -
Duodenal ulcer 10 80 % 20 % 10 %
Gastric ulcer 2 100 % - -
CA stomach 2 100 % - -
Mallory – Weiss tear 2 100 % - -
Dieulafoy’s lesion 1 100 % - -
Necrotising Pancreatitis 1 100 % - -
REFERENCE
1. Gilbert, D.A. et al. "The National ASGE
survey on upper Gl bleeding. III.
Endoscopy in upper grastrointestinal
bleeding" Gastrointest. Endosc. 27: 94-102.
2. Silverstein, F.G. et al. "The National ASGE
Survey on UGI bleeding. I. Study design and
baseline data". Gastrointest. Endosc.
1981.27:73-9. .
3. Eastwood, G.I. "Does the patient with upper
GI bleeding benefit from endoscopy?" Dig.
Dis. Sic. 1981. 26: 225.
4. Savary, P.J., Miller et a. "Hand book and Atlas of
Endoscopy" 1978.
5. Atkinson, ML, Bottrill, M.B. and Edwards A.T.,
"Mucosal tears at the esophagus gastric
junction: Gut 1961; 2: 1-11.
6. Jordan, S.M and Kiefer E.D. "Complications
of peptic ulcer; their prognostic
significance." JAMA 1934; 103: 2004-7.
7. Mathewson K., Pugh, S., Northfield T.C.
"Which peptic ulcer patients bleed?" Gut
1988; 29: 70-4.
8. Swain Paul, C. "Pathophysiology of bleeding
lesions" Gastroinest. Endosc. 1990; 36: 521-
23.
9. Hunt, P.S., Hansky, J., Korman, MG. "Mortality
in patients with haematemesis and melena;
a prospective study" Br. Med. J. 1979; 1:
1238-1240.
10. Karvoner, Al et al. "Gastric mucosal
erosions: AN endoscopic, histological and
functional study". Scand. J. Gastroenterol,
1983; 18: 1051.
11. Somerville K et al. "Non-steroidal anti-
inflammtory drugs and bleeding peptic
ulcer" Lancet 1986 ; 1: 462.
12. Lud et al. "Gastric aspiration in localization
of gastrointestinal haemorhage" JAMA 1979;
241: 576-578.
13. Cottonm P.B. et a; "early endoscopy of
oesophagus, stomach and duodenum in
patients with haematemesis ad melaena."
Arch. Surg. 1973; 197: 13-7.
14. Thomas G.E. et al. "Survey of management
of acute upper GI haemorrhage." J.R. Soc.
Med. 1978; 73: 90-5.
15. Foster et al. "Stigmata of recent
haemorrhage in diagnosis and prognosis of
upper GI he Br. Med. J. 1978, 1: 1173-1177.
16. Laurence, BH et al "Endoscopic laser
photocoagulation for bleeding peptic
ulcers". Lancet 1980; 1: 124-5.
17. Alam, P. et al "Randomised study of
massive bleeding from peptic ulceration".
Ann. Surg 1965; 162: 561-577.

5. 50
N.Sundresh et et al / Int. Jour. of Res. in Pharmacology and Pharmacotherapeutics Vol-1[1] 2012 [46-51]
www.ijrpp.com
18. Swain, CP, Salmon, PR "Gastrointestinal
bleeding upper GI tract". Scand. J.
Gastoenterol 1984; 19 (Suppl 102): 53-60.
19. Johnston, J.H. et al. "A comparison of bipolar
electrocoagulation and argon laser
photocoagulation with coaxial co2 in the
treatment of bleeding ulcers". Gastrointest.
Endosc. 1978; 28: 200-1.
20. Goodale, RL et al. "Rapid endoscopic control
of bleeding gastric* erosions by laser
radiation". Arch. Surg 1970; 101: 211.
21. Swain, CP. et al. "Cyanoacrylate glue fails to
stop bleeding from experimental gastric
ulcers". Gastroenterology 1977 ; 22: 1114.
22. A very- Jones F. Haematemesis and melaena.
Br Mod J 1947; 2: 441-446.
23. Hoerr SO, Dunphy JE, Gray S. Place of
surgery in emergency treatment of upper
gastrointestinal haemorrhage. Surg Gynecol
Obstet 1948 ; 87: 338-342.
24. Thorne FL, Nyhus LM. Treatment of massive
upper gastrointestinal haemorrhage. Am J
Surg 1965 ; 31: 413-419.
25. Gordon-Taylor G. The problem of bleeding
peptic ulcer. Br J Surg 1937; 25: 403-425.
26. Tanner NC, Desmond AM. The surgical
treatment of haematemesis and meaena.
Postgrad Med J 1950; 26: 253-266.
27. Tanner NC. The diagnosis and management
of massive haematemesis. Br J Surg 1964 ; 51:
754-756.
28. Hoerr SO. Massive bleeding from peptic
uieeration - discussion. Ann Surg 1965;
162:573.
29. Macleod IA, Mills PR. Factors identifying
the probability of further haemorrhage after
acute upper gastrointestinal haemorrhage. Br
J Surg 1982; 69: 256-258.
30. Northfield TC. Factors predisposing to
recurrent haemorrhage after acute
gastrointestinal bleeding. Br Med j 1971; 1:
26-28.
31. Hunt PD, Hansky J, Korman MG, et al.
Bleeding duodenal ulcer: reduction in
mortality with a planned approach. Br J Surg
1979; 66: 633-635.
32. Read RC, Huebl HC, Thai AP. Randomized
study of massive bleeding from peptic
uieeration. Ann Surg 1966 ; 162: 561-570
33. A very-Jones G, Hummer JWP. Acute
haematemesis and melaena from peptic
ulcertation. In Maingot R, ed. Vol 1, 6"' ed.
Abdominal operations, Appleton-Century-
Crofts, 1980; 419-430.
34. Himal HS, Perrauly C. Mzabi R. Upper
gastrointestinal haemorrhage: aggressive
management decreases mortality. Surgery
1978; 84:448-452.
35. Foster DN, Miloszewski KJA, Losowsky MS.
Stigmata of recent haemorrhage in diagnosis
and prognosis of upper gastrointestinal
bleeding. Br Med J 1978; 1: 1173-1177.
36. Griffiths WJ, Neumann DA, Welsh JD. The
visible vessel as an indicator of uncontrolled
or recurrent gastrointestinal haemorrhage.
NEngl JMed 1979; 300: 1411-1413.
37. Eastwood GL. Does early endoscopy benefit the
patient with upper gastrointestinal bleeding,
Gastroenterology 1977; 72: 737-739.
38. Cotton PB, Russell RC. Disease of the
alimentary system— haematermesis and
melaena. Br Med J 1977; 1: 37-39.
39. Venebles CW. Gastroduodenal surgery, In
Dykes PW, Keighley MRB, eds.
Gastrointestional Haemorrhage, Brisfol:
Wright PSg, 1981; 337-356.
40. Surgery. Jn H Dudley, ed. The abdomen .
Butterworths Lond, 1982; in press.
41. Hunt PS, Hansku J, Korman MG. Bleeding
carcinomatous ulcer of the stomach. Med J
Aus 1982; 1: 494.
42. Rockall TA et al. (1996) Risk assessment
after upper gastrointestinal haemorrhage.
Gut 38: 316-321.
43. Vreeburg EM et al. (1999) Validation of the
Rockall risk scoring system in upper
gastrointestinal bleeding. Gut 44: 331-335.
44. Barkum A et al. 92003) Consensus
recommendations for managing patients
with nonvaricela upper gastrointestional
bleeding. Ann Intern Med 139: 843-857.
45. Levine JE et al. (2002) Meta-analysis: the
efficacy of intravenous H2
-receptor
antagonists in bleeding peptic ulcer.
Aliment Pharmacol Ther 16(6): 1137-1142.
46. Collins R and Langman M (1985) Treatment
with histamine H2
antognists in acute upper
gastrointestinal hemorrhage N Engl J Med
131:660-666.
47. Daneshmend TK et al. (1992) Omeprazole
versus placebo for acute upper
gastrointestinal bleeding: randomized
double-blind controller trial. Br Med J 304:
143-147.
48. Lau JY et al. (2000) Effect of
intravenous omeprazole on recurrent
bleeding after endoscopic treatment of
bleeding peptic ulcers. NEnglJ Med 343: 310-
316.
49. Leontiaids GI et ai. (2004) Proton pump
inhibitor treatment for acute peptic ulcer
bleeding. The Cochrane Database of
Systematic Reviews, Issue 3, Art. No.
CD0002094.
50. Barkun A et al. (2004) Prevention of peptic
ulcer rebleeding using continuous infusion
of pantoprazole vs ranitidine: a
mulcicenter, multinational, randomized,
double-blind, parallel group comparison
[abstract]. Gastroenterol 126 (Suppl 4): A78.
51. Sacks HS et al. (1990) Endoscopic
hemostasis: an effective therapy for
bleeding peptic ulcers. JAMA 264: 494-499.
52. Cook DJ et al. (1992) Endoscopic therapy for
acute non-variceal upper gastrointestinal
hemorrhage - a meta-analysis. Gastrointest
Endosc 60:875-880.

6. 51
N.Sundresh et et al / Int. Jour. of Res. in Pharmacology and Pharmacotherapeutics Vol-1[1] 2012 [46-51]
www.ijrpp.com
53. Park CH et al. (2004) Optimal injection
volume of epinephrine for endoscopic
prevention of recurrent peptic ulcer
bleeding. Gastrointest Endosc 60: 455-461.
54. Gevers AM et al. (2002) A randomized trial
comparing injection therapy with hemoclip
and with injection combined with hemoclip
for bleeding ulcers. Gastrointest Endosc 55:
466-469.
55. Lau JYW et al. (1999) Endoscopic
retreatment compared with surgery in
patients with recurrent bleeding after initial
endoscopic control of bleeding ulcers. N
Engl J Med 340: 751- 756.
56. Graham FY et al. 91993) Treatment of
Helicobacter pylori reduces the rate of
rebleeding in peptic ulcer disease. Scan J
Gastroenterol 28: 939-942.
57. Green FW Jr, Kaplan MM, Curtis LE, Levine
PH. Effect of acid and pepsin on blood
coagulation and platelet aggregation: a
possible contributor prolonged
gastroduodenal mucosal hemorrhage.
Gastroenterology 1978; 74: 38-43.
58. Labenz J, Peitz U, Leusing C, Tillenbrug B,
Blum AL, Borsch G. Efficacy of primed
infusions with high dose ranitidine and
omeprazole to maintain higher intragastric
pH in patients with pepetic ulcer bleeding:
a prospective randomized controlled study.
Gut 1997; 40: 36-41.
59. Villanueva, C, Balanzo J, Torras X, et al.
Omeprazole versus ranitidine as adjunct
therapy to endoscopic injection in actively
bleeding ulcers: a prospective and
randomized study. Endoscopy 1995; 27: 308-
12.
60. Lin HJ, Lo WC, Lee FY, Perng CL, Tseng GY.
A prospective randomized comparative trial
showing that omeprazole prevents
rebleeding in patients with bleeding peptic
ulcer after successful endoscopic therapy.
Arch Intern Med 1998; 158: 54-8.
61. Andriulli A, Annese V, Camso M, eta 1.
Proton pump inhibitors and outcome of
endoscopic haemostasis in bleeding peptic
ulcer: a series of meta-analyses. American
Journal of Gastroenteology 2005; 100:207-
19.
62. Chan FK, Ching JY, Hung LC, et al.
Clopidogrel versus aspirin and
esomeprazole to prevent recurrent ulcer
bleeding. N Engl J Med 2005; 352: 238-44.
63. Steffs C, Fromm D. The current diagnosis
and management of upper gastrointestinal
bleeding. Adv Surg 1992; 25: 331-361.
64. Larson DE, Farnell MB.Upper
gastrointestinal haemorrhage. Mayo Clinic
Proc 1983; 58: 371-387.
65. Jones SC, Axon AT. Bleeding peptic ulcer -
endoscopic and pharmacologic management.
Postgrad Med J 1991; 67: 606-612.
66. Bornman PC, Graham SM, Dunn IP.
Complications of peptic ulcer and their
management, in: Taylor TV, Watson A,
Williamson RCN, (eds). Upper Digestive
Surgery. 1st ed. London: WB Saunders Co,
1999; 495-533.
67. Welch M, Hoare EM. The Dieuifoy gastic
malformation: an under-recognized cause
of massive upper gastrointestinal
haemorrhage. Postgrad Med J 1991; 67: 581-
583.
68. Langman MJS. Upper gastrointestinal
bleeding. In: Pounder RE (ed). Recent
advances in gastroenterology, vol. 6,
NewYork: Churchchill Livingstone, 1986: 1-
16.
69 Valle JD. Peptic ulcer disease and relate
disorders. In: Braunwald E, Fauci AS,
Kasper DL, Hauser SL, Longo DL, Jamesson
JL. (eds). Harrison's Principles of internal
Medicine. 15th ed. New York: Me Graw Hill,
2001: 1649-1665.